LBO — WASHINGTON CO REG MED CTR
IRR: 15.8% | MOIC: 2.08x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
15.8%
IRR
2.08x
MOIC
$52.2M
Entry EV
$76.2M
Exit EV
$26.8M
Equity Invested
Sources & Uses
S&UTotal · $52.2M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $20.3M | 38.8% | |
| Sub Debt | $5.1M | 9.7% | |
| Equity | $26.8M | 51.5% | |
| Enterprise Value | $50.6M | 97.1% | |
| Transaction Fees | $1.5M | 2.9% | |
| Total Uses | $52.2M | 100.0% |
Interpretation
INTAt 2.08x MOIC and 15.8% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $7.3M |
| Exit Ev | $76.2M |
| Net Debt At Exit | $20.3M |
| Equity At Exit | $55.9M |
| Equity Invested | $26.8M |
| Total Value Created | $29.1M |
| Value From Growth | $23.0M |
| Value From Multiple | $2.5M |
| Value From Deleveraging | $5.0M |